Acer Therapeutics Receives Complete Response Letter from U.S. FDA for use of Edsivo (celiprolol) in vEDS Patients June 25, 2019https://www.drugs.com/nda/edsivo_190625.html Acer Therapeutics Receives Complete Response Letter from U.S. FDA for use of Edsivo (celiprolol) in vEDS Patients
FDA Rejects Edsivo NDA for Vascular Ehlers-Danlos Syndrome June 25, 2019FDA Rejects Edsivo NDA for Vascular Ehlers-Danlos Syndrome FDA Rejects Edsivo NDA for Vascular Ehlers-Danlos Syndrome